The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: An evidence-based review

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 11, 2005, Pages 823-861

  Hahn, Theresa ^a   Wall, Donna ^b   Camitta, Bruce ^c   Davies, Stella ^d   Dillon, Hildy ^e   Gaynon, Paul ^f   Larson, Richard A ^g   Parsons, Susan ^h   Seidenfeld, Jerome ⁱ   Weisdorf, Daniel ^j   McCarthy Jr , Philip L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b TEXAS TRANSPLANT INSTITUTE   (United States)

^c CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e The Leukemia & Lymphoma Society   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h TUFTS UNIVERSITY   (United States)

ⁱ Blue Cross and Blue Shield Association   (United States)

^j UNIVERSITY OF MINNESOTA   (United States)

more..

Author keywords

Acute lymphoblastic leukemia; Hematopoietic stem cell transplantation; Pediatric; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MAFOSFAMIDE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD DONOR; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHILD CARE; CLINICAL TRIAL; CYTOTOXICITY; EVIDENCE BASED MEDICINE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL EXPERT; MINIMAL RESIDUAL DISEASE; OUTCOMES RESEARCH; PREDICTION; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ANTINEOPLASTIC AGENTS; CHILD; CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; PUBMED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 27844474315     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.08.035     Document Type: Review

References (92)

1. T. Hahn S.N. Wolff M.C. Czuczman et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma an evidence-based review Biol Blood Marrow Transplant 7 2001 308-331
2. T. Hahn J. Wingard K. Anderson et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma an evidence-based review Biol Blood Marrow Transplant 9 2003 4-37
3. Hahn T, Wall D, Camitta B, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: An evidence-based review. Biol Blood Marrow Transplant. In press.
4. R. Jones Y. Nieto J.D. Rizzo et al. The evolution of the evidence-based review: Evaluating the science enhances the art of medicine.-Statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation Biol Blood Marrow Transplant 11 2005 819-822
5. K.A. Wheeler S.M. Richards C.C. Bailey et al. Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: Results from Medical Research Council UKALL X and XI Blood 96 2000 2412-2418
6. J.M. Chessells C. Bailey K. Wheeler S.M. Richards Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: Experience in MRC UKALL X Lancet 340 1992 565-568
7. M. Arico M.G. Valsecchi B. Camitta et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia N Engl J Med 342 2000 998-1006
8. C. Uderzo M.G. Valsecchi A. Balduzzi et al. Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) Br J Haematol 96 1997 387-394
9. U.M. Saarinen L. Mellander K. Nysom et al. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: A retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO) Bone Marrow Transplant 17 1996 357-363
10. A. Sharathkumar E.F. Saunders Y. Dror et al. Allogeneic bone marrow transplantation vs chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukemia Bone Marrow Transplant 33 2004 39-45
11. A.J. Barrett M.M. Horowitz B.H. Pollock et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission N Engl J Med 331 1994 1253-1258
12. K. Wheeler S. Richards C. Bailey J. Chessells Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: The MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia Br J Haematol 101 1998 94-103
13. C. Uderzo M.G. Valsecchi A. Bacigalupo Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: Ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association J Clin Oncol 13 1995 352-358
14. G. Harrison S. Richards S. Lawson et al. Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party Ann Oncol 11 2000 999-1006
15. H. Schroeder G. Gustafsson U.M. Saarinen-Pihkala et al. Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: A population-based case control study from the Nordic countries Bone Marrow Transplant 23 1999 555-560
16. BFM Relapse Study Group A. Borgmann R. Hartmann H. Schmid et al. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: A comparison between treatment results of chemotherapy and bone marrow transplantation Bone Marrow Transplant 15 1995 515-521
17. A. Borgmann A. von Stackelberg R. Hartmann et al. Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: A matched pair analysis Blood 101 2003 3835-3839
18. P.M. Hoogerbrugge E.J. Gerritsen A. vd Does-van den Berg et al. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children Bone Marrow Transplant 15 1995 255-259
19. The Berlin-Frankfurt-Munster Study Group A. Borgmann H. Schmid R. Hartmann et al. Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: A matched-pair analysis Lancet 346 1995 873-876
20. AIEOP/FONOP-TMO group Associzione Italiana Emato-Oncologia Pediatrica C. Messina M.G. Valsecchi M. Arico et al. Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia Bone Marrow Transplant 21 1998 9-14
21. F. Boulad P. Steinherz B. Reyes et al. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: A single-institution study J Clin Oncol 17 1999 197-207
22. S.A. Feig R.E. Harris H.N. Sather Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: A study of the Children's Cancer Group (CCG-1884) Med Pediatr Oncol 29 1997 534-540
23. A. Torres F. Martinez P. Gomez et al. Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymphoblastic leukemia in second complete remission Bone Marrow Transplant 4 1989 609-612
24. F.L. Johnson E.D. Thomas B.S. Clark R.L. Chard J.R. Hartmann R. Storb A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission N Engl J Med 305 1981 846-851
25. A. Bacigalupo M.T. Van Lint F. Frassoni et al. Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission Bone Marrow Transplant 1 1986 75-80
26. AIEOP/FONOP-TMO Group Italian Association of Paediatric Haemato-Oncology C. Messina S. Cesaro R. Rondelli et al. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy Bone Marrow Transplant 21 1998 1015-1021
27. M.S. Maldonado C. Diaz-Heredia I. Badell et al. Autologous bone marrow transplantation with monoclonal antibody purged marrow for children with acute lymphoblastic leukemia in second remission. Spanish Working Party for BMT in Children Bone Marrow Transplant 22 1998 1043-1047
28. A.L. Billett E. Kornmehl N.J. Tarbell et al. Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia Blood 81 1993 1651-1657
29. S.E. Sallan C.M. Niemeyer A.L. Billett et al. Autologous bone marrow transplantation for acute lymphoblastic leukemia J Clin Oncol 7 1989 1594-1601
30. P. Colleselli F. Rossetti C. Messina et al. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia in remission: first choice for isolated extramedullary relapse? Bone Marrow Transplant 14 1994 821-825
31. C. Canals C. Torrico M. Picon et al. Immunomagnetic bone marrow purging in children with acute lymphoblastic leukemia J Hematother 6 1997 261-268
32. G. Lonnerholm B. Simonsson J. Arvidson et al. Autologous bone marrow transplantation in children with acute lymphoblastic leukemia Acta Paediatr 81 1992 1017-1022
33. I. Houtenbos F. Bracho V. Davenport et al. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: A novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC) Bone Marrow Transplant 27 2001 145-153
34. J.L. Pico O. Hartmann D. Maraninchi et al. Modified chemotherapy with carmustine, cytarabine, cyclophosphamide, and 6-thioguanine (BACT) and autologous bone marrow transplantation in 24 poor-risk patients with acute lymphoblastic leukemia J Natl Cancer Inst 76 1986 1289-1293
35. N. Ramsay T. LeBien M. Nesbit et al. Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: Results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement Blood 66 1985 508-513
36. H. Schmid G. Henze R. Schwerdtfeger et al. Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia Bone Marrow Transplant 12 1993 597-602
37. F. Rossetti C. Messina R. Miniero et al. ABMT for early isolated extramedullary relapse of childhood ALL Bone Marrow Transplant 12 1993 37-41
38. A. Balduzzi G. Gaipa S. Bonanomi et al. Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: Evidence for long-term clinical and molecular remissions Leukemia 15 2001 50-56
39. A. Grañena X. Castellsague I. Badell et al. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: Clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement Bone Marrow Transplant 24 1999 621-627
40. J. Garcia C. Punti M. Picon et al. Bone marrow purging in acute lymphoblastic leukemia: Biological and clinical features J Hematother 3 1994 203-211
41. A.J. Barrett M.M. Horowitz R.P. Gale et al. Marrow transplantation for acute lymphoblastic leukemia: Factors affecting relapse and survival Blood 74 1989 862-871
42. C. Weyman J. Graham-Pole S. Emerson et al. Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: A multicenter survey Bone Marrow Transplant 11 1993 43-50
43. A. Borgmann E. Baumgarten H. Schmid et al. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: A conceivable alternative? Bone Marrow Transplant 20 1997 939-944
44. Å. Gustafsson Jernberg M. Remberger O. Ringdén J. Winiarski Graft-versus-leukemia effect in children: Chronic GVHD has a significant impact on relapse and survival Bone Marrow Transplant 31 2003 175-181
45. J.A. Brochstein N.A. Kernan S. Groshen et al. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia N Engl J Med 317 1987 1618-1624
46. M. Zecca A. Pession C. Messina et al. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings J Clin Oncol 17 1999 1838-1846
47. C.H.M. Jamieson M.D. Amylon R.M. Wong K.G. Blume Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: A 15-year experience Exp Hematol 31 2003 981-986
48. A. von Bueltzingsloewen H. Esperou-Bourdeau G. Souillet et al. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: A Cooperative Study of the Societe; Francaise de Greffe de Moelle Bone Marrow Transplant 16 1995 521-527
49. G.R. Buchanan G.K. Rivera B.H. Pollock et al. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: A Pediatric Oncology Group Study Cancer 88 2000 1166-1174
50. B.G. Gordon P.I. Warkentin S.E. Strandjord et al. Allogeneic bone marrow transplantation for children with acute leukemia: Long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation Bone Marrow Transplant 20 1997 5-10
51. J.E. Sanders E.D. Thomas C.D. Buckner K. Doney Marrow transplantation for children with acute lymphoblastic leukemia in second remission Blood 70 1987 324-326
52. A.J. Shah C. Lenarsky N. Kapoor et al. Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation J Pediatr Hematol Oncol 26 2004 91-97
53. M. Moussalem H. Esperou Bourdeau A. Devergie et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: Factors predictive of survival, relapse and graft-versus-host disease Bone Marrow Transplant 15 1995 943-947
54. P. Bordigoni J.P. Vernant G. Souillet et al. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia in first remission: A cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse J Clin Oncol 7 1989 747-753
55. P.F. Coccia S.E. Strandjord P.I. Warkentin et al. High-dose cytosine arabinoside and fractionated total-body irradiation: An improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission Blood 71 1988 888-893
56. J.R. Wingard S. Piantadosi G.W. Santos et al. Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia J Clin Oncol 8 1990 820-830
57. D.R. Fleming P.J. Henslee-Downey E.H. Romond et al. Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: a comparative matched cohort study Bone Marrow Transplant 17 1996 917-922
58. A. Green E. Clarke L. Hunt et al. Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome Blood 94 1999 2236-2246
59. A. Oakhill D.H. Pamphilon M.N. Potter et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission Br J Haematol 94 1996 574-578
60. N. Bunin M. Carston D. Wall et al. Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission Blood 99 2002 3151-3157
61. A. Balduzzi T. Gooley C. Anasetti et al. Unrelated donor marrow transplantation in children Blood 86 1995 3247-3256
62. S.M. Davies J.E. Wagner X.O. Shu et al. Unrelated donor bone marrow transplantation for children with acute leukemia J Clin Oncol 15 1997 557-565
63. P. Lang R. Handgretinger D. Niethammer et al. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia Blood 101 2003 1630-1636
64. D.I. Marks J.M. Bird J.M. Cornish et al. Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia J Clin Oncol 16 1998 931-936
65. G. Dini M. Grazia Valsecchi C. Micalizzi et al. Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission Bone Marrow Transplant 32 2003 325-331
66. B.F. Lausen C. Heilmann L. Vindelov N. Jacobsen Outcome of acute lymphoblastic leukaemia in Danish children after allogeneic bone marrow transplantation. Superior survival following transplantation with matched unrelated donor grafts Bone Marrow Transplant 22 1998 325-330
67. U.M. Saarinen-Pihkala G. Gustafsson N. Carlsen et al. Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation Pediatr Blood Cancer 42 2004 8-23
68. U.M. Saarinen-Pihkala G. Gustafsson O. Ringden et al. No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission J Clin Oncol 19 2001 3406-3414
69. N. Bunin R. Aplenc N. Kamani K. Shaw A. Cnaan S. Simms Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: A Pediatric Blood and Marrow Transplant Consortium study Bone Marrow Transplant 32 2003 543-548
70. S.M. Davies N.K. Ramsay J.P. Klein et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia J Clin Oncol 18 2000 340-347
71. D.J. Weisdorf W.G. Woods M.E. Nesbit Jr et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: Risk factors and clinical outcome Br J Haematol 86 1994 62-69
72. P.A. Carpenter G.M. Marshall N. Giri M.R. Vowels S.J. Russell Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan Bone Marrow Transplant 18 1996 489-494
73. E. Granados R. de La Camara L. Madero et al. Hematopoietic cell transplantation in acute lymphoblastic leukemia: Better long term event-free survival with conditioning regimens containing total body irradiation Haematologica 85 2000 1060-1067
74. D.J. Weisdorf A.L. Billett P. Hannan et al. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia Blood 90 1997 2962-2968
75. C. Uderzo R. Rondelli G. Dini et al. High-dose vincristine, fractionated total-body irradiation and cyclophosphamide as conditioning regimen in allogeneic and autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission: A 7-year Italian multicentre study Br J Haematol 89 1995 790-797
76. S.K. Parsons S.M. Castellino L.E. Lehmann et al. Relapsed acute lymphoblastic leukemia: Similar outcomes for autologous and allogeneic marrow transplantation in selected children Bone Marrow Transplant 17 1996 763-768
77. S.E. Lawson G. Harrison S. Richards et al. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: A report on the medical research council UKALLR1 study Br J Haematol 108 2000 531-543
78. F. Giona A.M. Testi R. Rondelli et al. ALL R-87 protocol in the treatment of children with acute lymphoblastic leukaemia in early bone marrow relapse Br J Haematol 99 1997 671-677
79. A.M. Testi M.L. Moleti F. Giona et al. Treatment of primary refractory or relapsed acute lymphoblastic leukemia (ALL) in children Ann Oncol 3 1992 765-767
80. F. Giona A.M. Testi L. Annino et al. Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: The GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologia ed Ocologia Pediatrica Br J Haematol 86 1994 55-61
81. AIEOP and GIMEMA Cooperative Groups F. Giona L. Annino A.M. Testi et al. Management of advanced acute lymphoblastic leukemia in children and adults: Results of the ALL R-87 protocol Leuk Lymphoma 32 1998 89-95
82. O. Ringden M. Labopin E. Gluckman et al. Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling?. A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) study Bone Marrow Transplant 19 1997 963-968
83. W.G. Woods N.K.C. Ramsay D.J. Weisdorf et al. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: Lack of superiority over cyclophosphamide-containing conditioning regimens Bone Marrow Transplant 6 1990 9-16
84. B. Bostrom D.J. Weisdorf T. Kim J.H. Kersey N.K. Ramsay Bone marrow transplantation for advanced acute leukemia: A pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide Bone Marrow Transplant 5 1990 83-89
85. S.R. Rheingold N.J. Bunin R. Aplenc A.M. Leahey B. Lange Long term survival using intensive multiagent chemotherapy for relapses of pediatric acute lymphoblastic leukemia (ALL) [abstract] Blood 104 2004 539a
86. D.A. Jacobsohn B. Hewlett E. Morgan R.E. Duerst M. Kletzel Favorable outcome for infant ALL following hematopoietic stem cell transplantation (HSCT) [abstract] Blood 104 2004 592a
87. F. Locatelli M. Zecca A. Pession et al. Outcome of children with ALL given HSCT from unrelated volunteers has significantly improved over time and now is comparable to that of children transplanted from an HLA-identical sibling [abstract] Blood 104 2004 593a
88. M.I. Gharib H.M. Greenfield R.F. Wynn et al. Alemtuzumab (Campath 1H) in conditioning therapy with cyclophosphamide and total body irradiation in matched and mismatched unrelated donor transplantation of children with acute lymphoblastic leukemia: A report from 3 U.K. centres [abstract] Blood 104 2004 593a
89. A. Watanabe N. Katano A. Kikuta et al. Strategy of cumulative dose reduction of drugs with late effects, using escalating dose of anti-metabolites with or without mega-dose chemotherapy plus autologous peripheral blood stem cell rescue for treatment of childhood acute lymphoblastic leukemia: Children's Cancer and Leukemia Study Group of Japan (CCSLG), CCLSG ALL 941 Protocol Study Blood 102 2003 223a [abstr]
90. M. Eapen M.M. Horowitz J.P. Klein et al. Comparable long-term survival after unrelated donor bone marrow or umbilical cord blood and HLA-identical sibling transplants for treatment of acute leukemia in infants [abstract] Blood 102 2003 245a
91. P.J. Lang J. Greil P. Bader et al. Haploidentical transplantation in pediatric patients with ALL: A comparison with unmanipulated grafts [abstract] Blood 102 2003 486a
92. National Cancer Policy Board Childhood Cancer Survivorship Improving Care and Quality of Life 2003 National Academies Press Washington, DC